Abstract

Critical components of the HU RCMI Program collaborations and partnerships efforts are 1) the Pilot Projects Key Activity, 2) providing HU investigators training on Team Science or the Science of Collaboration, 3) stimulating enhanced collaboration among HU core facilities, and 4) providing enhanced access to RTRN collaboration support services. The collaborative pilot projects program will be discussed in section 3.4 as an independent key activity. The other aspects of the collaborations and partnerships effort are discussed in this section. As a result, the Pilot Projects and Collaborations and Partnership Key Activities collectively comprised the HU RCMI collaboration effort and are responsive to specific aim 3 of this proposal. The Pilot Projects Key Activity is focused on the direct stimulation/enhancement of collaborative efforts, while the Collaborations and Partnership Key Activity is primarily focused on training and access to resources. The Collaborations and Partnerships Key Activity directly addresses HU's biomedical research goal of encouraging multi-disciplinary approaches to research in the pursuit of those diseases that disproportionately affect minorities and disadvantaged populations.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
2G12MD007597-26
Application #
8845407
Study Section
Special Emphasis Panel (ZMD1-MLS (01))
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-03-31
Support Year
26
Fiscal Year
2014
Total Cost
$1,131,624
Indirect Cost
$381,018

  Institution

Name
Howard University
Department
Type
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059

  Publications

Tigabu, Bersabeh; Ramanathan, Palaniappan; Ivanov, Andrey et al. (2018) PHOSPHORYLATED VP30 OF MARBURG VIRUS IS A REPRESSOR OF TRANSCRIPTION. J Virol :
Morris, Kevin F; Billiot, Eugene J; Billiot, Fereshteh H et al. (2018) Investigation of Chiral Recognition by Molecular Micelles with Molecular Dynamics Simulations. J Dispers Sci Technol 39:45-54
Southerland, William M; Swamidass, S Joshua; Payne, Philip R O et al. (2018) The diversity and disparity in biomedical informatics (DDBI) workshop. Pac Symp Biocomput 23:614-617
Wang, Ze-Jun; Heinbockel, Thomas (2018) Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases. Molecules 23:
Khaibullina, Alfia; Adjei, Elena A; Afangbedji, Nowah et al. (2018) RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice. Haematologica 103:787-798
Fawzy, Ashraf; Putcha, Nirupama; Paulin, Laura M et al. (2018) Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. Respir Res 19:20
Wingate, La'Marcus T; Stubbs, Keisha; Ahmed, Iman et al. (2018) The Economic Impact of Herpes Zoster Vaccine Disparities in Elderly United States Blacks. Int J Environ Res Public Health 15:
Ivanov, Andrey; Lin, Xionghao; Ammosova, Tatiana et al. (2018) HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription. Retrovirology 15:39
Jerebtsova, Marina; Saraf, Santosh L; Soni, Simran et al. (2018) Urinary orosomucoid is associated with progressive chronic kidney disease stage in patients with sickle cell anemia. Am J Hematol 93:E107-E109
Jerebtsova, Marina; Saraf, Santosh L; Lin, Xionghao et al. (2018) Identification of ceruloplasmin as a biomarker of chronic kidney disease in urine of sickle cell disease patients by proteomic analysis. Am J Hematol 93:E45-E47

Showing the most recent 10 out of 251 publications